SCHEMBL4902126

SCHEMBL4902126

[S]SC1=NC=CCC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3040934 0.84
SCHEMBL10784568 0.67
SCHEMBL10659032 0.67
SCHEMBL9297975 0.62
SCHEMBL2899010 0.60
Bromide SCHEMBL11114085 0.59
SCHEMBL4786313 0.53
SCHEMBL8988872 0.53
SCHEMBL7656436 0.50
SCHEMBL6781825 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10155046-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2018-12-18 US claimed
US-20160120993-A1 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2016-05-05 US claimed
US-9216227-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2015-12-22 US claimed
US-10155046-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2018-12-18 US disclosed
US-10155045-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2018-12-18 US disclosed
EP-3138855-A1 ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION Lipoxen Technologies Limited (GB) 2017-03-08 EP disclosed
EP-1853634-B1 ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION LIPOXEN TECHNOLOGIES LTD (GB) 2016-08-10 EP disclosed
US-20160120993-A1 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2016-05-05 US disclosed
US-20160101186-A1 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2016-04-14 US disclosed
US-9216227-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2015-12-22 US disclosed
US-20150150997-A1 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2015-06-04 US disclosed
US-8952141-B2 Activated sialic acid derivatives for protein derivatisation and conjugation Lipoxen Technologies Incorporated (GB) 2015-02-10 US disclosed
US-8735557-B2 Activated sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2014-05-27 US disclosed
US-20140141486-A1 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2014-05-22 US disclosed
US-20130095548-A1 ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION LIPOXEN TECHNOLOGIES LIMITED (GB) 2013-04-18 US disclosed
US-8217154-B2 Biodrug delivery LIPOXEN TECHNOLOGIES LIMITED (GB) 2012-07-10 US disclosed
US-20080262209-A1 Activated Sialic Acid Derivatives for Protein Derivatisation and Conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2008-10-23 US disclosed
EP-1853634-A1 ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION Lipoxen Technologies Limited (GB) 2007-11-14 EP disclosed
WO-2006090119-A1 ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION LIPOXEN TECHNOLOGIES LIMITED (GB) 2006-08-31 WO disclosed